Related Experiment Video
Updated: Jan 16, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1
A Morales1, E Korsakova2, N Mansooralavi3
1Molecular Biology Institute, UCLA, Los Angeles, CA 90095, USA; Department of Molecular Cell and Developmental Biology, UCLA, Los Angeles, CA 90095, USA.
Abstract:
Methyl-CpG-binding protein 2 (MECP2)/Rett syndrome is characterized by a postnatal loss of neurophysiological function and regression of childhood development. While Rett neurons have been described as showing elevated senescence and P53 activity, here we show that molecular and physiological dysfunction in neurons lacking MECP2 is triggered by elevated DNA damage. Using human induced pluripotent stem cell (hiPSC)-derived isogenic lines, we find that MECP2 directly interacts with members of the DNA repair machinery, including PARP1. Here, we present evidence that MECP2 also regulates PARP1 activity, and restoration of PARP1 activity in MECP2-null neurons can reverse DNA damage, senescence, dendritic branching defects, and metabolic dysfunction. These data from a human disease-in-a-dish model system support the notion that dysfunction in Rett syndrome neurons could be caused by changes in PARP activity.
Insights
Rett syndrome, caused by MECP2 loss, triggers neuronal dysfunction via DNA damage. Restoring PARP1 activity in these neurons reverses damage and developmental defects, suggesting PARP1 as a therapeutic target.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Rett syndrome is a neurodevelopmental disorder characterized by loss of motor skills and cognitive function.
- Neurons in Rett syndrome models exhibit senescence and P53 activity, but the underlying cause of dysfunction is unclear.
Purpose of the Study:
- To investigate the molecular mechanisms driving neuronal dysfunction in Methyl-CpG-binding protein 2 (MECP2)-null neurons.
- To explore the role of DNA damage and repair pathways in Rett syndrome pathogenesis.
Main Methods:
- Utilized human induced pluripotent stem cell (hiPSC)-derived isogenic lines to model MECP2 deficiency.
- Investigated the interaction between MECP2 and DNA repair proteins, specifically PARP1.
- Assessed the impact of restoring PARP1 activity on neuronal function.
Main Results:
- MECP2-null neurons exhibit elevated DNA damage, which triggers molecular and physiological dysfunction.
- MECP2 directly interacts with and regulates the activity of PARP1, a key DNA repair enzyme.
- Restoring PARP1 activity in MECP2-deficient neurons ameliorated DNA damage, senescence, dendritic defects, and metabolic issues.
Conclusions:
- Neuronal dysfunction in Rett syndrome is driven by elevated DNA damage, not solely senescence or P53 activity.
- MECP2 plays a crucial role in regulating DNA repair via PARP1.
- Modulating PARP1 activity presents a potential therapeutic strategy for Rett syndrome.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Long-patch Base Excision Repair
DNA Damage can Stall the Cell Cycle

